1Owens RC,Rice L.Hospital-based strategies for combating resistance[J].Clin Infect Dis,2006,42(Supp1.4):S173-S181.
2Nahum GG,Uhl K,Kennedy DL.Antibiotic use in pregnancy and lactation:what is and is not known about teratogenic and toxic risks[J].Obstet Gynecol,2006,107(5):1120-1138.
3Mann MS,Faro S,Maccato ML,et al.Treatment of cervical chlamydial infection with amoxicillin/clavulanic potassium[J].Infect Dis Obstet Gynecol,1993,1(2):104-107.
4Czeizel AE,Rockenbauer M,Srensen HT,et al.Use of cephalosporins during pregnancy and in the presence of congenital abnormalities:A population-based,case-control study[J].Am J Obstet Gynecol,2001,184(6):1289-1296.
5Tita AT,Owen J,Stamm AM,et al.Impact of extended-spectrum antibiotic prophylaxis on incidence of postcesarean surgical wound infection[J].Am J Obstet Gynecol,2008,199(3):303.e1-e3.
9Nagarajan R.Antibacterial activities and modes of action of vancomycin and related glycopeptides[J].Antimicrob Agents Chemother,1991,35(4),605
10Sharman GJ,Williams DH.Common factors in the mode of action of vancomycin group antibiotics active against resistant bacteria[J].Chem Commun,1997,723
6Arsenijevic L,Popovic N, Gojnic M. Nosocomial infections inthe intensive care unit of a gynecology clinic[J]. MedicinskiPregled,2010,59(3-4) : 165-168.
